| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| December 11, 2023 | Chief Medical Officer | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- | |
| October 3, 2022 | Director | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- | |
| July 20, 2022 | Director, President and CEO | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- | |
| June 9, 2021 | Director | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- | |
| June 8, 2021 | Director | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- | |
| March 19, 2013 | CFO | Form 4 | Open market or private sale of non-derivative or derivative security | 37,272 | $1.06 | -- | |
| December 18, 2012 | SVP & Chief Financial Officer | Form 4 | Exercise of in-the-money or at-the-money derivative security | 8,636 | $2.77 | -- | |
| December 5, 2012 | Director | Form 4 | Exercise of in-the-money or at-the-money derivative security | 34,583 | $3.25 | -- | |
| September 20, 2012 | Director | Form 4 | Exercise of in-the-money or at-the-money derivative security | 18,735 | $4.22 | -- | |
| August 9, 2011 | Director | Form 4 | Conversion of derivative security | 41 | -- | -- | |
| March 23, 2011 | CMO | Form 4 | Conversion of derivative security | 6 | -- | -- | |
| March 23, 2011 | CFO | Form 4 | Conversion of derivative security | 8 | -- | -- | |
| March 23, 2011 | Director | Form 4 | Conversion of derivative security | 12 | -- | -- | |
| March 23, 2011 | Director | Form 4 | Conversion of derivative security | 83 | -- | -- | |
| March 23, 2011 | CEO | Form 4 | Conversion of derivative security | 41 | -- | -- | |
| March 23, 2011 | Controller & CAO | Form 4 | Conversion of derivative security | 8 | -- | -- | |
| January 8, 2010 | Interim Chief Accnt Officer | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- | |
| January 8, 2010 | Interim Chief Accnt Officer | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- | |
| January 8, 2010 | Interim Chief Accnt Officer | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- | |
| June 17, 2008 | VP & Chief Medical Officer | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- | |
| June 17, 2008 | VP & Chief Medical Officer | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- | |
| June 17, 2008 | VP & Chief Medical Officer | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- | |
| June 17, 2008 | VP & Chief Medical Officer | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- | |
| June 17, 2008 | VP & Chief Medical Officer | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- | |
| June 17, 2008 | VP & Chief Medical Officer | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.
